Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. (RCKT) Stock Overview

Explore Rocket Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

RCKT●NASDAQ
HealthcareBiotechnology
$3.50
$0.02(0.43%)
U.S. Market opens in 17h 28m

Rocket Pharmaceuticals, Inc. (RCKT)

Meyka AI Score

Z

Key Financials

Market Cap383.3M
P/E Ratio-22.04
EPS (TTM)$-0.17
ROE-0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$4.03
3 Months$5.46
1 Year Target$0.00

RCKT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Rocket Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RCKT on the NASDAQ shows an RSI of 53.14, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Rocket Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of -22.04 and a market capitalization of 383.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of RCKT on the NASDAQ.

Price Performance (NASDAQ: RCKT)

1-Day Change
0.86%
5-Day Change
5.41%
1-Month Change
3.24%
3-Month Change
12.86%
6-Month Change
-7.14%
Year-to-Date (YTD) Change
N/A
1-Year Change
-5.90%
3-Year Change
-77.90%
5-Year Change
-88.38%
All-Time (Max) Change
-85.38%

Contact Information

https://rocketpharma.com
609 659 8001
9 Cedarbrook Drive, Cranbury, NJ, 08512

Company Facts

2,020 Employees
IPO DateFeb 18, 2015
CountryUS
Actively Trading

Frequently Asked Questions